Immunogenicity and reactogenicity of 23-valent pneumococcal polysaccharide vaccine among pregnant Filipino women and placental transfer of antibodies

Vaccine

Volumn 25, Issue 22, 2007, Pages 4470-4477

  Quiambao, Beatriz P ^a   Nohynek, Hanna M ^b   Käyhty, Helena ^b   Ollgren, Jukka P ^b   Gozum, Lorena S ^a   Gepanayao, Connie P ^a   Soriano, Victoria C ^a   Makela, Pirjo Helena ^b  

^a RESEARCH INSTITUTE FOR TROPICAL MEDICINE   (Philippines)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Antibodies; Maternal immunization; Pneumococcus

Indexed keywords

HAEMOPHILUS INFLUENZAE TYPE B VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY RESPONSE; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG FEVER; ENZYME IMMUNOASSAY; FACE EDEMA; FEMALE; FILIPINO; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; INJECTION SITE ERYTHEMA; INJECTION SITE INDURATION; INJECTION SITE PAIN; INJECTION SITE SWELLING; NORMAL HUMAN; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND TRIMESTER PREGNANCY; SEROTYPE; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE; TETANUS; THIRD TRIMESTER PREGNANCY; UMBILICAL CORD BLOOD; URBAN POPULATION;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; FEMALE; FETAL BLOOD; HUMANS; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION PROGRAMS; INFANT, NEWBORN; PHILIPPINES; PNEUMOCOCCAL VACCINES; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 34248230345     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.021     Document Type: Article

References (43)

1. Shann F., Germer S., Hazlett D., Gratten M., Linnemann V., and Payne R. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet September (1984) 537-541
2. Usen S., Adegbola R., Mulholland K., Jaffar S., Hilton S., Oparaugo A., et al. Epidemiology of invasive pneumococcal disease in the Western Region, The Gambia. Pediatr Infect Dis J 17 1 (1998) 23-28
3. O'Dempsey T.J.D., McArdle T.F., Lloyd-Evans N., Baldeh I., Lawrence B.E., Secka O., et al. Pneumococcal disease among children in a rural area of West Africa. Pediatr Infect Dis J 15 (1996) 431-437
4. The WHO Young Infants Study Group. Bacterial etiology of serious infections in young infants in developing countries: results of a multi-center study. Pediatr Infect Dis J 18 (1999) S17-S22
5. Tupasi T.E., Lucero M.G., Magdangal D.M., Mangubat N., Sunico E., Torres C., et al. Etiology of acute lower respiratory infections in children from Alabang, Metro Manila. Rev Infect Dis 12 Suppl. 8 (1990) S929-S939
6. Gatchalian S.G., Quiambao B.P., Morelos A.M., Abraham L., Gepanayao C.P., Sombrero L.T., et al. Bacterial and viral etiology of serious infections in very young Filipino infants. Pediatr Infect Dis J 18 (1999) S50-S55
7. Lupisan S., Herva E., Sombrero L., Quiambao B., Capeding R., Abucejo E., et al. Invasive bacterial infections of children in a Rural Province in Central Philippines. Am J Trop Med Hyg 62 3 (2000) 341-346
8. Black S., Shinefield H., Frieman B., Lewis E., Ray P., Hansen J., et al. Efficacy, safety and immunogenicity of heptavalent Pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
9. O'Brien K., Moulton L., Reid R., Weatherholtz R., Hackell J., Kohberger R., et al. Invasive disease efficacy of a 7-valent Pneumococcal conjugate vaccine among Navajo or White Mountain Apache (N/WMA) children. Abstract presented in the annual meeting of the European society of pediatric infectious diseases. Istanbul, Turkey, March (2001) 26-28
10. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N., et al. A trial of a 9-valent Pneumococcal conjugate vaccine in children with and those without HIV infection. NEJM 349 14 (2003) 1341-1348
11. Cutts F.T., Zaman S.M., Enwere G., Jaffar S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 (2005) 1139-1146
12. Madhi S.A., Kuwanda L., Cutland C., and Klugman K. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of Pneumonia in HIV-infected and -uninfected children. Clin Infect Dis 40 (2005) 1511-1518
13. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakosko J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. NEJM 344 (2001) 403-409
14. Kilpi T., Ahman H., Jokinen J., Lankinen K.S., Palmu A., Savolainen H., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 (2003) 1155-1164
15. Prymula R., Peeters P., Chrobok V., Kriz P., Novakova E., Kaliskova E., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
16. Williams C., Pilishvili T., Farley M., Schaffner W., Craig A., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368 (2006) 1495-1502
17. Lucero M.G., Williams G., Tamundong A., Tallo V., and Riley I.D. Timeliness of immunization for EPI vaccines in Bohol, Philippines: preparing for a pneumococcal conjugate vaccine efficacy trial. Int J TB and Lung Dis 2 November (2 Suppl. 2) (1998) S383
18. Halsey N.A., and Klein D. Maternal immunization. Pediatr Infect Dis J 9 8 (1990) 574-581
19. Mulholland K. Maternal immunization for the prevention of bacterial infections in young infants. Vaccine 16 14/15 (1998) 1464-1467
20. Glezen W.P., and Alpers M. Maternal Immunization. Clin Infect Dis 28 (1999) 219-224
21. WHO meeting on maternal and neonatal pneumococcal immunization. Weekly Epidemiological Record, June 1998; 25:187.
22. O'Dempsey T.J.D., McArdle T., Ceesay S.J., Banya W.A.S., Demba E., Secka O., et al. Immunization with a pneumococcal capsular polysaccharide vaccine during pregnancy. Vaccine 14 10 (1996) 963-970
23. Riley I., and Douglas R. An epidemiological approach to pneumococcal disease. Rev Infect Dis 3 2 (1984) 233-245
24. Lehmann D., Pomat W., Combs B., Dyke T., and Alpers M. Maternal immunization with pneumococcal polysaccharide vaccine in the Highlands of Papua New Guinea. Vaccine 20 (2002) 1837-1845
25. Lehmann D., Pomat W., Riley I., and Alpers M. Studies of maternal immunization with pneumococcal polysaccharide vaccine in Papua New Guinea. Vaccine 21 (2003) 3446-3450
26. Shahid N., Steinhoff M.C., Hoque S.S., Begum T., Thompson C., and Siber G.R. Serum, breast milk and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 346 (1995) 1252-1257
27. Muňoz F., Englund J., Cheesman C., Maccato M., Pinell P., Nahm M., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the third trimester of gestation. Vaccine 20 (2002) 826-837
28. Barker J., Gratten M., Riley I., Lehmann D., Montgomery J., Kaioi M., et al. Pneumonia in children in the Eastern Highlands of Papua New Guinea: a bacteriologic study of patients selected by standard clinical criteria. J Infect Dis 159 (1989) 348-352
29. Pneumococcal vaccines: WHO Position Paper. Weekly Epidemiological Record, 1999. 74:177-183.
30. Koskela M., Leinonen M., Timonen M., and Makela P.H. First and second dose antibody response to pneumococcal polysaccharide vaccine in infants. Pediatr Infect Dis J 5 1 (1986) 45-50
31. Capeding M.R.Z., Sombrero L.T., Lucero M.G., and Saniel M.C. Serotype distribution and antimicrobial resistance of invasive Streptococcus pneumoniae isolates in Filipino children. J Infect Dis 169 (1994) 479-480
32. Gepanayao C., Nohynek H., Capeding R., Sombrero L., Tamundong A., Lucero M., et al. Upper respiratory tract carriage of Streptococcus pneumoniae among healthy Filipino infants. Int J Tuberc Lung Dis 2 11 Suppl. 2 (1998) S275
33. Quiambao B., Nohynek H., Kayhty H., Ollgren J., Gozum L., Gapanayao C., et al. Maternal immunization with pneumococcal polysaccharide vaccine in the Philippines. Vaccine 21 (2003) 3451-3454
34. Nohynek H., Quiambao B., Gepanayao C., Eerola M., and Makela P.H. Immunization in pregnancy. Safety Evaluation of the 23-valent pneumococcal polysaccharide vaccine. Abstract presented in the conference on pneumococcal vaccines for the world. Washington DC, USA (October 1998) 12-14
35. Käyhty H., Åhman H., Rönnberg P.-R., Tiilikainen R., and Eskola J. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children. J Infect Dis 172 (1995) 1273-1278
36. World Health Organization. Pneumococcal conjugate vaccines. Recommendations for the production and control of pneumococcal conjugate vaccines. WHO Technical Report Series No. 927, Annex 2, 2005. http://www.who.int/biologicals/publications/trs/areas/vaccines/pneumo/en /index.html.
37. Sarvas H., Seppälä I., Kurikka S., Siegberg R., and Mäkelä O. Half-life of the maternal IgG1 allotype in infants. J Clin Immunol 13 (1993) 145-151
38. Kurikka S., Käyhty H., Peltola H., Saarinen L., Eskola J., and Mäkelä P.H. Neonatal immunization: response to Haemophilus influenzae type b-Tetanus Toxoid conjugate vaccine. Pediatrics 95 (1995) 815-822
39. Hedlund T., Kalin M., Ortqvist A., and Henrichsen J. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch Int Med 154 (1994) 1961-1965
40. Sankilampi U., Honkanen P., Pyhola R., and Leinonen M. Association of pre-vaccination antibody levels with adverse reactions to Pneumococcal and Influenza Vaccine Administration Simultaneously in the Elderly. Vaccine 15 10 (1997) 1133-1137
41. Pönkä A., and Leinonen M. Adverse reactions to polyvalent pneumococcal vaccine. Scand J Infect Dis 14 (1982) 67-71
42. Nieminen T., Eskola J., and Kayhty H. Pneumococcal conjugate vaccine in adults: circulating antibody secreting cell response and humoral antibody responses in saliva and in serum. Vaccine 16 6 (1998) 630-636
43. Wuorimaa T., Käyhty H., Leroy O., and Eskola J. Tolerability and immunogenicity of an 11-valent pneumococcal conjugate vaccine in adults. Vaccine 19 (2001) 1863-1869